R. Ziesche (Vienna, Austria), T. Alfaro (Coimbra, Portugal), A. Corlateanu (Chishinau, Republic of Moldova), V. Poletti (Forli, Italy)
The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
H. Nishikiori, H. Chiba, M. Otsuka, K. Kuronuma, H. Takahashi (Sapporo, Japan)
|  |
Characteristics of inspiratory and expiratory reactance in interstitial lung disease
H. Iwamoto, N. Hattori, Y. Haruta, A. Sugiyama, I. Nakamura, M. Nakagawa, S. Miyamoto, Y. Onari, N. Ishikawa, K. Fujitaka, H. Murai, N. Kohno (Hiroshima, Japan)
| |
The efficacy of pirfenidone in scleroderma related interstitial lung disease
Y. Miura, Y. Tsunoda, T. Tanaka, H. Takoi, Y. Yatagai, S. Rin, A. Sekine, K. Hayashihara, T. Saito, A. Gemma, A. Azuma (Ibaraki, Tokyo, Japan)
| |
Effect of pirfenidone on chronic interstitial pneumonia
H. Takoi, Y. Miura, Y. Tsunoda, Y. Sumazaki, T. Tanaka, S. Y. Lin, Y. Yatagai, A. Sekine, K. Hayashihara, T. Saito (Ibaraki, Tokyo, Japan)
| |
Telephone consultations for follow-up of interstitial lung disease: Patient satisfaction survey
R. Adhikary, L. Cheyne, P. Beirne (Leeds, United Kingdom)
| |
NSIP: A diagnosis?
T. Nivière, P. A. Gevenois, B. Bondue, P. De Vuyst (Brussels, Belgium)
| |
6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID)
S. Nathan, C. Albera, R. du Bois, W. Bradford, U. Costabel, T. King, P. Noble, S. Sahn, D. Valeyre (Falls Church, Brisbane, San Francisco, Durham, Charleston, United States Of America; Turin, Italy; London, United Kingdom; Essen, Germany; Paris, France)
| |
The efficacy of transbronchail biopsies without fluoroscopy control in diagnostics of extrinsic allergic alveolitis
I. Sivokozov, O. Lovacheva, E. Shmelev (Moscow, Russian Federation)
| |
KL-6 compared to LDH as a prognostic factor in Caucasian patients with idiopathic pulmonary fibrosis
S. Ohshimo, F. Bonella, Y. Horimasu, N. Ishikawa, N. Hattori, N. Hirohashi, K. Tanigawa, N. Kohno, J. Guzman, U. Costabel (Hiroshima, Japan; Essen, Bochum, Germany)
| |
Improved and immediate diagnostics in mediastinal sarcoid lymphadenopathy via endobronchial ultrasound and quadruple testing
D. Dhasmana, C. Bradley, D. Connell, P. George, A. Singanayagam, A. Jepson, C. Craig, C. Wright, P. Molyneaux, A. Lalvani, G. Cooke, O. M. Kon (London, United Kingdom)
|  |
Viral infection immunodetection reinforce the possible viral participation in the pulmonary fibrosis disease
G.C. dos Santos, E.R. Parra, F.W. Stegun, C. Cirqueira, M.I. Duarte, V. Capelozzi (Sao Paulo, Brazil)
| |
Pirfenidone, proton pump inhibitor, N acetyl cysteine (PINPOINT) therapy for IPF: Tolerance and safety profile among Indian patients
P. Chhajed, H.S. Sandeep, P. Chaudhari, S. Subramanian, D. Miedinger, J. Leuppi, A. Kate (Vashi, Navi Mumbai, Mumbai, India)
| |
Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma
W. Chebbi, S. Ayed, N. Boudawara, L. Boussoffara, S. Mahjoub, M. H. Sfar, J. Knani (Mahdia, Monastir, Tunisia)
| |
Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early single centre Irish experience
P. Barry, L. Murphy, M. Tuohy, E. Judge, J. Egan (Dublin, Ireland)
| |
UIP-like or NSIP pattern in interstitial lung disease patients (ILD), following by ‘connective tissue disease ‘(CTD)
M. Dimadi, R. Trigidou, G. Isaakides, S. Tassi, M. Salomidou, L. Thanos, E. Sepsas, K. Malagari (Athens, Greece)
| |
Pulmonary functions in systemic sclerosis
A. Khoury, F. Abou-Trabeh, S. Hamdoun (Aleppo, Syrian Arab Republic)
| |
Analysis of cases from an interstitial lung disease (ILD) MDT in a teaching hospital in the West Midlands: Patients with smoking-related disease comprise 11% of cases and have a median age of 50 years
S. Ejiofor, F. Woodhead, E. Helm (Coventry, United Kingdom)
| |
A retrospective cohort study of interstitial lung diseases in Denmark
C. Hyldgaard, E. Bendstrup, O. Hilberg (Aarhus C, Denmark)
| |
Respiratory bronchiolitis interstitial lung disease – What is the natural history?
A. Low, J. Viner, A. Edey, A. Millar (Bristol, United Kingdom)
| |
Spontaneous pneumomedistinum & subcutaneous emphysema in idiopathic pulmonary fibrosis (IPF) with bronchial wall leak
C. Patel, R. Chopra, V. Pandharkar, A. Yannawar, J. Gaikwad, M. Bhosle, S. Patil (Pune, India)
| |